|
MCF7-LEM4
|
>4 μmol L−1
|
Cellular viability assay (SRB assay)
|
Download PDF
|
|
BT474-shLEM4
|
120 nmol L−1
|
Cellular viability assay (SRB assay)
|
Download PDF
|
|
MCF-7 cells
|
13 nM
|
CyQuant fluorescent DNA-binding dye kit
|
Download PDF
|
|
MCF-7 cells
|
6.3 nM
|
ERE-tk109-Luc reporter gene assay, detected by Bright Glo luciferase reagent
|
Download PDF
|
|
MCF-7
|
25.56 µmol/L
|
MTT assay
|
Download PDF
|
|
T47D
|
35.28 µmol/L
|
MTT assay
|
Download PDF
|
|
ZR-75
|
31.14 µmol/L
|
MTT assay
|
Download PDF
|
|
MDA-MB-231
|
39.68 µmol/L
|
MTT assay
|
Download PDF
|
|
MCF7
|
5.03 μM
|
Cell viability assay (e.g., Colony formation assay, CCK-8 assay)
|
Download PDF
|
|
MCF7/TAMR
|
37.29 μM
|
Cell viability assay (e.g., Colony formation assay, CCK-8 assay)
|
Download PDF
|
|
Cryptococcus neoformans isolates
|
8 mg/L
|
Microbroth antifungal susceptibility testing as per CLSI guidelines (MIC90 measurement)
|
Download PDF
|
|
C. gattii isolates
|
8 mg/L
|
Microbroth antifungal susceptibility testing as per CLSI guidelines (MIC90 measurement)
|
Download PDF
|
|
VCaP cells
|
20 µM
|
MTS proliferation assay and/or Resazurin assays
|
Download PDF
|
|
PC-3 cells
|
20 µM
|
MTS proliferation assay and/or Resazurin assays
|
Download PDF
|
|
MCF7 cells
|
12.5 mM
|
Cell viability assay
|
Download PDF
|
|
NCI-H295R
|
5.43 µM
|
MTT dye reduction assay for cell viability, TC20 automated cell counter for cell proliferation.
|
Download PDF
|
|
M-HeLa
|
28 ± 2.5 µM
|
Cell Viability Bio App using Cytell Cell Imaging system; IC50 calculated using Quest Graph – IC50Calculator
|
Download PDF
|
|
MCF-7
|
25 ± 2.2 µM
|
Cell Viability Bio App using Cytell Cell Imaging system; IC50 calculated using Quest Graph – IC50Calculator
|
Download PDF
|
|
T98G
|
42.1 ± 3.5 µM
|
Cell Viability Bio App using Cytell Cell Imaging system; IC50 calculated using Quest Graph – IC50Calculator
|
Download PDF
|
|
Chang Liver
|
42.1 ± 3.5 µM
|
Cell Viability Bio App using Cytell Cell Imaging system; IC50 calculated using Quest Graph – IC50Calculator
|
Download PDF
|
|
MCF-7 cells
|
50 µM
|
cytotoxicity assay
|
Download PDF
|
|
MCF-7 cell
|
40.78 ± 0.48 µM
|
cytotoxicity assay
|
Download PDF
|
|
MCF-7 and T-47D cell lines
|
34.42 ± 0.83 µM (MCF-7), 42.40 ± 0.78 µM (T-47D)
|
proliferation inhibition assay
|
Download PDF
|
|
breast papillary carcinoma organoids
|
19.13 μmol
|
CellTiter-Glo3D reagent luminescence assay, data analyzed using GraphPad Prism 6 and determined manually.
|
Download PDF
|
|
MCF-7
|
6.5 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
LCC2
|
67.7 µM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
MCF-7
|
7.5 mM
|
Resazurin reduction assay
|
Download PDF
|
|
MDA-MB-231
|
9.5 mM
|
Resazurin reduction assay
|
Download PDF
|
|
TAM-resistant MCF-7
|
25.9 mM
|
Resazurin reduction assay
|
Download PDF
|
|
TAM-resistant MDA-MB-231
|
23.4 mM
|
Resazurin reduction assay
|
Download PDF
|
|
EO771
|
14 µM
|
Cell viability measured by fluorescence using resazurin solution
|
Download PDF
|
|
MCF-7
|
~15 µM
|
Cell viability measured by fluorescence using resazurin solution
|
Download PDF
|
|
EO771
|
14 µM
|
Cell viability measured by fluorescence using resazurin solution
|
Download PDF
|
|
EO771
|
14 µM
|
Multiplex Biomarker Immunoassays (Luminex system)
|
Download PDF
|
|
BT474 cells
|
32.13 µM
|
MTT reduction assay
|
Download PDF
|
|
GES-1 cells
|
25.90 μmol/L
|
MTT assay
|
PMC12968642
|
|
GES-1 cells
|
12.57 μmol/L
|
MTT assay
|
PMC12968642
|
|
MCF-7 cells
|
2.34 ± 0.27 µg/mL
|
SRB assay
|
Download PDF
|
|
ZR75.1 parental cells
|
12 µM
|
Not explicitly stated, from previous compound experiments
|
Download PDF
|
|
MCF7
|
5 μmol/l
|
SRB assay
|
Download PDF
|
|
MCF7/Tam
|
10 μmol/l
|
SRB assay
|
Download PDF
|
|
MCF-7
|
2.4 μM
|
MTT assay
|
Download PDF
|
|
MCF-7R
|
9.4 μM
|
MTT assay
|
Download PDF
|
|
MCF-7
|
10 µM
|
Cell viability measured by crystal violet staining
|
Download PDF
|
|
BC3f
|
68.4 µM
|
MTT assay
|
Download PDF
|
|
BC4f
|
8.4 µM
|
MTT assay
|
Download PDF
|
|
BrC4f
|
26.92 µM
|
MTT assay
|
Download PDF
|
|
BN120f
|
19.46 µM
|
MTT assay
|
Download PDF
|
|
NSK1f
|
15.6 µM
|
MTT assay
|
Download PDF
|
|
MCF7
|
49.5 µM
|
MTT assay
|
Download PDF
|
|
MCF7, T47D
|
5 μM
|
CCK-8 assay
|
Download PDF
|
|
MCF-7
|
52.78 mM
|
MTT assay, calculated with GraphPad Prism 5.0 using non-linear regression (curve fit) log (agonist) vs. normalized response-variable slope.
|
Download PDF
|
|
MCF-7 TAM-R
|
605.5 mM
|
MTT assay, calculated with GraphPad Prism 5.0 using non-linear regression (curve fit) log (agonist) vs. normalized response-variable slope.
|
Download PDF
|
|
MCF-7
|
6.16 μM
|
MTT reduction assay
|
Download PDF
|
|
MCF-7Var-H
|
7.64 μM
|
MTT reduction assay
|
Download PDF
|
|
MCF-7Var-I
|
12.36 μM
|
MTT reduction assay
|
Download PDF
|
|
A549 cells
|
72 ±9 μM
|
Crystal violet assay
|
Download PDF
|
|
H1975 cells
|
37 ±5 μM
|
Crystal violet assay
|
Download PDF
|
|
BEAS-2B cells
|
9 ±0.2 μM
|
Crystal violet assay
|
Download PDF
|
|
MCF-7 breast cancer cells
|
5.45 μM
|
MTT test analysis
|
PMC11840623
|
|
T47D
|
4.2 μM
|
MTT method
|
Download PDF
|
|
MCF-7
|
3.2 μM
|
MTT method
|
Download PDF
|
|
BT-474
|
5.7 μM
|
MTT method
|
Download PDF
|
|
A375
|
30 μM
|
MTT assay
|
Download PDF
|
|
B16F10
|
40 μM
|
MTT assay
|
Download PDF
|
|
B16F1
|
30 μM
|
MTT assay
|
Download PDF
|
|
T47D
|
3.53 µmol/L
|
CCK8 assay
|
PMC7259490
|
|
T47DR/LV-NC
|
8.68 µmol/L
|
CCK8 assay
|
PMC7259490
|
|
T47DR/LV-sh-SRC
|
4.78 µmol/L
|
CCK8 assay
|
PMC7259490
|
|
T47DR/LV-OE-SRC
|
13.96 µmol/L
|
CCK8 assay
|
PMC7259490
|
|
IOMM cells
|
8.02 μM
|
CCK8 assay
|
PMC12988422
|
|
MCF7
|
2.499 µM
|
CCK-8 assay
|
PMC12148429
|
|
MCF7/Tam1
|
54.29 μM
|
CCK-8 assay
|
PMC12148429
|
|
CR cells (Case 1)
|
1.1 µM
|
CellTiter-Glo® 3D cell viability assay
|
Download PDF
|
|
CR cells (Case 2)
|
13.8 µM
|
CellTiter-Glo® 3D cell viability assay
|
Download PDF
|
|
CR cells (Case 3)
|
38.3 µM
|
CellTiter-Glo® 3D cell viability assay
|
Download PDF
|
|
CR cells (Case 4)
|
25.1 µM
|
CellTiter-Glo® 3D cell viability assay
|
Download PDF
|
|
MCF-7
|
9.86 ± 0.23 μM
|
MTS assay
|
Download PDF
|
|
MCF-7
|
5.25 ± 0.19 μM
|
MTS assay
|
Download PDF
|
|
MCF-7
|
2.90 ± 0.17 μM
|
MTS assay
|
Download PDF
|
|
MCF-7
|
1.36 ± 0.10 μM
|
MTS assay
|
Download PDF
|
|
TAM-MCF7
|
>50 μM
|
MTS assay
|
Download PDF
|
|
TAM-MCF7
|
36.74 ± 0.89 μM
|
MTS assay
|
Download PDF
|
|
TAM-MCF7
|
21.32 ± 0.41 μM
|
MTS assay
|
Download PDF
|
|
TAM-MCF7
|
14.23 ± 0.28 μM
|
MTS assay
|
Download PDF
|
|
TAM-MCF7
|
9.92 ± 0.21 μM
|
MTS assay
|
Download PDF
|
|
T47D
|
12.81 ± 0.19 μM
|
MTS assay
|
Download PDF
|
|
HCC Subtype S1 (predicted from GDSC cell line data)
|
45.62
|
oncoPredict algorithm based on GDSC database
|
Download PDF
|
|
HCC Subtype S2 (predicted from GDSC cell line data)
|
28.32
|
oncoPredict algorithm based on GDSC database
|
Download PDF
|
|
MCF7-R
|
>6 μM
|
sulforhodamine B assay
|
Download PDF
|
|
T47D
|
7.0±0.8μM
|
WST assay
|
Download PDF
|
|
T47D/FT
|
40.8±1.4μM
|
WST assay
|
Download PDF
|
|
MCF-7
|
7.6±1.0μM
|
WST assay
|
Download PDF
|
|
MCF-7/FT
|
13.4±1.4μM
|
WST assay
|
Download PDF
|
|
BT-474
|
8.4±1.4μM
|
WST assay
|
Download PDF
|
|
BT-474/FT
|
47.5±7.0μM
|
WST assay
|
Download PDF
|
|
MCF-7
|
16.11 μM
|
CCK-8 assay
|
PMC9011257
|
|
MCF-7R
|
65.53 μM
|
CCK-8 assay
|
PMC9011257
|
|
MCF-7
|
5.72 ± 0.62 µg/mL
|
MTT assay
|
PMC11415995
|
|
MDA-MB-231
|
8.18 ± 0.67 µg/mL
|
MTT assay
|
PMC11415995
|
|
MDA-Doxo400
|
3.582 ± 0.048 μM (alone); 4.336 ± 0.895 μM (with PSC-833)
|
Cell proliferation assay
|
Download PDF
|
|
CHORC5/huBcl-2
|
1.49 ± 0.23 μM
|
In-vitro proliferation assay
|
Download PDF
|
